Evidence map›Paper›PMID 42168722›Full record

ArticleMolecular neurobiology2026

Mild Cognitive Impairment Associated with Obstructive Sleep Apnoea: A Pilot Study on Oxygen-Related Plasma Biomarkers and Network Analysis.

Martina De Felice, Alessia Pascazio, Rebecca Piccarducci, Lorenzo Germelli, Martina Cirinciani, Jonathan Fusi, Simona Cintoli, Martina Ulivi, Maria Letizia Trincavelli, Ferdinando Franzoni and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Martina De Felice *Department of Pharmacy, University of Pisa, Pisa, 56126, Italy.ORCID http://orcid.org/0000-0001-7704-8705
Alessia Pascazio *Department of Clinical and Experimental Medicine, University of Pisa, Pisa, 56126, Italy.ORCID http://orcid.org/0000-0003-1574-0717
Rebecca PiccarducciDepartment of Pharmacy, University of Pisa, Pisa, 56126, Italy.ORCID http://orcid.org/0000-0001-9577-6650
Lorenzo GermelliDepartment of Pharmacy, University of Pisa, Pisa, 56126, Italy.ORCID http://orcid.org/0000-0002-7318-7545
Martina CirincianiDepartment of Pharmacy, University of Pisa, Pisa, 56126, Italy.ORCID http://orcid.org/0009-0008-4209-761X
Jonathan FusiDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, 56126, Italy.ORCID http://orcid.org/0000-0002-7905-6423
Simona CintoliDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, 56126, Italy.ORCID http://orcid.org/0000-0001-6921-307X
Martina UliviDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, 56126, Italy.
Maria Letizia TrincavelliDepartment of Pharmacy, University of Pisa, Pisa, 56126, Italy.ORCID http://orcid.org/0000-0001-8124-977X
Ferdinando FranzoniDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, 56126, Italy.ORCID http://orcid.org/0000-0003-2132-8788
Filippo BaldacciDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, 56126, Italy.ORCID http://orcid.org/0000-0002-8752-0556
Paolo MilazzoDepartment of Computer Science, University of Pisa, Pisa, 56126, Italy.ORCID http://orcid.org/0000-0002-7309-6424
Claudia MartiniDepartment of Pharmacy, University of Pisa, Pisa, 56126, Italy.ORCID http://orcid.org/0000-0001-9379-3027
Eleonora Da PozzoDepartment of Pharmacy, University of Pisa, Pisa, 56126, Italy. eleonora.dapozzo@unipi.it.ORCID http://orcid.org/0000-0003-4762-8949
Michelangelo MaestriDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, 56126, Italy.ORCID http://orcid.org/0000-0003-0960-4938
Enrica BonanniDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, 56126, Italy.ORCID http://orcid.org/0000-0001-8500-1149

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obstructive sleep apnoea syndrome (OSAS) is a breathing disorder frequently associated with mild cognitive impairment (MCI), a potential prodromal stage of Alzheimer's disease (AD). However, the mechanisms underlying MCI in OSAS remain unclear, making the identification of early biomarkers crucial. This pilot study investigates biochemical parameters related to oxygen disturbance and AD in OSAS patients with and without MCI (OSAS + MCI and OSAS-MCI, respectively) and explores their interplay through a network-based analysis. A total of 45 subjects (30 OSAS patients; 15 healthy controls) were enrolled, undergoing clinical assessment, polygraphy, and blood sampling. Compared to controls, OSAS patients exhibited increased apnoea-hypopnea index, oxygen desaturation index, and the percentage of cumulative time with oxygen saturation below 90% during total sleep time (T90). Notably, in the entire OSAS cohort, T90 positively correlated with HIF-1α levels, which were higher than controls, although not significantly. Interestingly, both T90 and HIF-1α were elevated in OSAS + MCI patients compared to OSAS-MCI, confirming a positive correlation between their levels. Regarding AD-related biomarkers, t-Tau and p-Tau

Indexed as

BiomarkersCognitive DysfunctionOxygenSleep Apnea, ObstructiveAgedFemaleHumansHypoxia-Inducible Factor 1, alpha SubunitMaleMiddle AgedPilot Projectstau ProteinsBiomarkersHypoxia-Inducible Factor 1, alpha SubunitOxygentau ProteinsHIF-1αMild cognitive impairmentNetwork-based analysisObstructive sleep apnoea syndromeP-Tau181T-Tau

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.